Skip to main content

Table 3 Differences between vitamin D treated and placebo treated at day 150

From: High-dose vitamin D3 supplementation shows no beneficial effects on white blood cell counts, acute phase reactants, or frequency of respiratory infections

Day 150

n

Vitamin D3

Mean (SD)

n

Placebo

Mean (SD)

P-value

25(OH)D3 (nmol/L)

129

89 (21)

136

51 (27)

< 0.001

Hemoglobin (mmol/L)

134

9.3 (0.52)

135

9.2 (0.58)

0.497

Thrombocytes (109/L)

133

234 (43)

135

233 (49)

0.548

Leucocytes (109/L)

133

6.0 (1.6)

135

6.0 (1.6)

0.702

Neutrophils (109/L)

133

3.2 (1.1)

135

3.2 (1.1)

0.893

Basophils (109/L)

133

0.036 (0.02)

135

0.033 (0.02)

0.215

Eosinophils (109/L)

133

0.21 (0.14)

135

0.21 (0.15)

0.938

Monocytes (109/L)

133

0.47 (0.16)

135

0.46 (0.17)

0.601

Lymphocytes (109/L)

133

2.1 (0.65)

135

2.0 (0.67)

0.582

CRP (mg/L)

134

1.3 (2.1)

136

1.9 (4.8)

0.136

Ferritin (ug/L)

133

185 (121)

135

176 (102)

0.482

Orosomucoid (g/L)

132

0.76 (0.17)

135

0.77 (0.18)

0.714

  1. The effect of treatment after 150 days. The data are presented as means with a standard deviation (SD) enclosed in parenthesis. P-values: Student’s t-test. Abbreviations: BMI, body mass index; 25(OH)D3, 25-hydroxyvitamin D3; CRP, C-reactive protein